This is the authors' abstract. We don't add key points for this paper.
S ummary The management of a patient with acquired haemophilia who sustained a compound fracture of the tibia is described. Haemostasis was achieved with infusions of large doses of porcine antihaemophilic globulin (AHG) and human cryoprecipitate. Investigations of the patient's antibody showed that when it was in excess it initially inactivated both porcine and human factor VIII rapidly, and then at a rate which decreased with progressive incubation. This decreasing rate of factor VIII inactivation differs from the action of a classically described factor VIII antibody which inactivates factor VIII in a linear manner when the antibody is in excess. It is suggested that the patient was more amenable to treatment with concentrated preparations of factor VIII than a patient with the classical type of factor VIII antibody, infused factor VIII persisting for longer in the patient's circulation than might be expected.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
PB Kernoff (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: